FDA 510(k) FDA class 2 Substantially Equivalent 🇺🇸 United States

VISTAKON (GALYFILCON A) SOFT CONTACT LENS

K Number: K032340 · Decision Oct 16, 2003
Classifications
1
FEI Numbers
130
Registration Numbers
130
Same Product Code
485
Applicant Total
12
Review Days
79

Research this 510(k) in seconds

The Research Assistant summarizes clearance history, predicates and product-code trends — and cites every record.

Free to try · every answer cites its records

Basic Information

Device Name
VISTAKON (GALYFILCON A) SOFT CONTACT LENS
K Number
K032340
Device Class
FDA class 2
Clearance Type
Traditional
Regulation Number
886.5925
Medical Specialty
Ophthalmic
Decision
Substantially Equivalent
Statement or Summary
Summary
Applicant
Johnson & Johnson Vision Care, Inc.
Date Received
July 29, 2003
Decision Date
October 16, 2003
Product Code
LPL
Advisory Committee
Ophthalmic
Review Advisory Committee
OP
Third Party
N

Classifications

This FDA 510(k) entry is associated with 1 FDA classification via its product code.

Product Code Device Name
LPL Lenses, Soft Contact, Daily Wear

Similar 510(k) Clearances

Other 510(k) clearances with the same product code (LPL), ordered by most recent decision date.

View all

Other Clearances by Johnson & Johnson Vision Care, Inc.

K Number Device Name
K210930 ACUVUE® OASYS MAX 1-DAY Contact Lenses (senofilcon A)
K200243 ACUVUE (senofilcon A) Soft Contact Lens Multifocal
K180299 ACUVUE OASYS (senofilcon A) with Photochromic Additive
K160212 ACUVUE (senofilcon C) Soft Contact Lens
K141670 ACUVUE (ETAFILCON A) SOFT CONTACT LENS FOR PRESBYOPIA
K100349 VISTAKON (NARAFILCON B) CONTACT LENS VISIBILITY TINTED WITH UV BLOCKER
K073485 VISTAKON (NARAFILCON) A SOFT CONTACT LENS
K062614 VISTAKON (ETAFILCON A) SOFT (HYDROPHILIC) CONTACT LENS, CLEAR AND TINTED (VISIBILITY AND/OR COSMETICALLY)
K051900 ACUVUE (ETAFILCON A) CONTACT LENS, CLEAR AND WITH VISIBILITY TINT WITH UV BLOCKER, FOR DAILY WEAR
K024177 ACUVUE 2 COLOURS BRAND (ETAFILCON A) SOFT (HYDROPHILIC) CONTACT LENS WITH UV BLOCKER
Search all 12 clearances from Johnson & Johnson Vision Care, Inc. →